Tandem Diabetes Care, Inc. Investing Cash Flow
Tandem Diabetes Care, Inc. (TNDM) reported Investing Cash Flow of -$282.78 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-06
- Tandem Diabetes Care, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$87.34M, a 250.24% decline year-over-year.
- Tandem Diabetes Care, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$195.45M, a 2227.67% decline year-over-year.
- Tandem Diabetes Care, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$14.98M, a 398.92% decline year-over-year.
- Tandem Diabetes Care, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $20.54M.
- Tandem Diabetes Care, Inc. net cash provided by (used in) investing activities for fiscal 2025 was $72.88M.
- Tandem Diabetes Care, Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$23.48M.
- Tandem Diabetes Care, Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$85.74M, a 358.50% decline from fiscal 2022.
- Tandem Diabetes Care, Inc. net cash provided by (used in) investing activities for fiscal 2022 was $33.17M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$87.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$282.78M 10-Q · filed 2026-08-06 | -$297.76M derived: sum of 3 quarters · filed 2026-08-06 | -$277.22M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$195.45M 10-Q · filed 2026-05-07 | -$210.42M derived: sum of 2 quarters · filed 2026-05-07 | -$189.89M derived: sum of 3 quarters · filed 2026-05-07 | -$131.76M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$14.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $5.56M derived: sum of 2 quarters · filed 2026-02-19 | $63.69M derived: sum of 3 quarters · filed 2026-08-06 | $72.88M 10-K · filed 2026-02-19 |
| 2025-09-30 | $20.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $78.67M derived: sum of 2 quarters · filed 2026-08-06 | $87.85M 10-Q · filed 2025-11-06 | $92.86M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $58.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $67.32M 10-Q · filed 2026-08-06 | $72.33M derived: sum of 3 quarters · filed 2026-08-06 | $52.43M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $9.19M 10-Q · filed 2026-05-07 | $14.20M derived: sum of 2 quarters · filed 2026-05-07 | -$5.70M derived: sum of 3 quarters · filed 2026-05-07 | -$9.24M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $5.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$14.89M derived: sum of 2 quarters · filed 2026-02-19 | -$18.43M derived: sum of 3 quarters · filed 2026-02-19 | -$23.48M 10-K · filed 2026-02-19 |
| 2024-09-30 | -$19.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$23.44M derived: sum of 2 quarters · filed 2025-11-06 | -$28.49M 10-Q · filed 2025-11-06 | -$45.08M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | -$3.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$8.60M 10-Q · filed 2025-08-06 | -$25.18M derived: sum of 3 quarters · filed 2026-02-19 | -$73.70M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | -$5.06M 10-Q · filed 2025-04-30 | -$21.64M derived: sum of 2 quarters · filed 2026-02-19 | -$70.17M derived: sum of 3 quarters · filed 2026-02-19 | -$64.47M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | -$16.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$65.11M derived: sum of 2 quarters · filed 2026-02-19 | -$59.41M derived: sum of 3 quarters · filed 2026-02-19 | -$85.74M 10-K · filed 2026-02-19 |
| 2023-09-30 | -$48.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$42.83M derived: sum of 2 quarters · filed 2024-11-06 | -$69.16M 10-Q · filed 2024-11-06 | -$33.38M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $5.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$20.63M 10-Q · filed 2024-08-01 | $15.15M derived: sum of 3 quarters · filed 2025-02-26 | $983.00K derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | -$26.33M 10-Q · filed 2024-05-02 | $9.45M derived: sum of 2 quarters · filed 2025-02-26 | -$4.71M derived: sum of 3 quarters · filed 2025-02-26 | $1.64M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $35.78M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $21.61M derived: sum of 2 quarters · filed 2025-02-26 | $27.97M derived: sum of 3 quarters · filed 2025-02-26 | $33.17M 10-K · filed 2025-02-26 |
| 2022-09-30 | -$14.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$7.81M derived: sum of 2 quarters · filed 2023-11-01 | -$2.61M 10-Q · filed 2023-11-01 | -$79.43M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $6.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $11.55M 10-Q · filed 2023-08-03 | -$65.26M derived: sum of 3 quarters · filed 2024-02-21 | -$104.47M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $5.20M 10-Q · filed 2023-05-03 | -$71.62M derived: sum of 2 quarters · filed 2024-02-21 | -$110.82M derived: sum of 3 quarters · filed 2024-02-21 | -$175.59M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | -$76.82M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | -$116.02M derived: sum of 2 quarters · filed 2024-02-21 | -$180.78M derived: sum of 3 quarters · filed 2024-02-21 | -$186.88M 10-K · filed 2024-02-21 |
| 2021-09-30 | -$39.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$103.96M derived: sum of 2 quarters · filed 2022-11-02 | -$110.06M 10-Q · filed 2022-11-02 | -$169.68M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | -$64.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$70.86M 10-Q · filed 2022-08-03 | -$130.48M derived: sum of 3 quarters · filed 2023-02-22 | -$268.31M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | -$6.09M 10-Q · filed 2022-05-04 | -$65.72M derived: sum of 2 quarters · filed 2023-02-22 | -$203.54M derived: sum of 3 quarters · filed 2023-02-22 | -$335.07M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | -$59.63M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$197.45M derived: sum of 2 quarters · filed 2023-02-22 | -$328.97M derived: sum of 3 quarters · filed 2023-02-22 | -$296.06M 10-K · filed 2023-02-22 |
| 2020-09-30 | -$137.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$269.35M derived: sum of 2 quarters · filed 2021-11-03 | -$236.43M 10-Q · filed 2021-11-03 | -$257.33M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | -$131.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$98.61M 10-Q · filed 2021-08-04 | -$119.51M derived: sum of 3 quarters · filed 2022-02-22 | -$141.68M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $32.92M 10-Q · filed 2021-05-05 | $12.02M derived: sum of 2 quarters · filed 2022-02-22 | -$10.16M derived: sum of 3 quarters · filed 2022-02-22 | -$24.82M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | -$20.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | -$43.07M derived: sum of 2 quarters · filed 2022-02-22 | -$57.73M derived: sum of 3 quarters · filed 2022-02-22 | -$56.95M 10-K · filed 2022-02-22 |
| 2019-09-30 | -$22.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$36.83M derived: sum of 2 quarters · filed 2020-11-05 | -$36.05M 10-Q · filed 2020-11-05 | -$42.65M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | -$14.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | -$13.88M 10-Q · filed 2020-07-30 | -$20.47M derived: sum of 3 quarters · filed 2021-02-24 | -$67.28M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $778.00K 10-Q · filed 2020-04-30 | -$5.81M derived: sum of 2 quarters · filed 2021-02-24 | -$52.62M derived: sum of 3 quarters · filed 2021-02-24 | -$80.45M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | -$6.59M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$53.40M derived: sum of 2 quarters · filed 2021-02-24 | -$81.22M derived: sum of 3 quarters · filed 2021-02-24 | -$90.74M 10-K · filed 2021-02-24 |
| 2018-09-30 | -$46.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | -$74.63M derived: sum of 2 quarters · filed 2019-11-04 | -$84.15M 10-Q · filed 2019-11-04 | -$85.57M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | -$27.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$37.34M 10-Q · filed 2019-08-01 | -$38.76M derived: sum of 3 quarters · filed 2020-02-24 | -$39.00M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | -$9.51M 10-Q · filed 2019-04-30 | -$10.93M derived: sum of 2 quarters · filed 2020-02-24 | -$11.18M derived: sum of 3 quarters · filed 2020-02-24 | |
| 2017-12-31 | -$1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | -$1.66M derived: sum of 2 quarters · filed 2020-02-24 | $2.78M 10-K · filed 2020-02-24 | |
| 2017-09-30 | -$244.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $4.20M 10-Q · filed 2018-11-01 | ||
| 2017-06-30 | $4.45M 10-Q · filed 2018-07-30 | |||
| 2016-12-31 | $10.45M 10-K · filed 2019-02-26 | |||
| 2014-03-31 | -$30.63M 10-Q · filed 2014-05-06 | |||
| 2013-03-31 | -$1.40M 10-Q · filed 2014-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |